You're reading the free version. Trader adds the live tape and alerts.
Start tracking
ALKS Sale Disclosure
Hopkinson Craig C. · SEC Form 4 · Filed Aug 3, 2026
Sale
Calculated transaction value
$437.22K
Hopkinson Craig C. EVP R&D, Chief Medical Officer
ALKS
Alkermes Inc
ALKS
Transaction date
Aug 3, 2026
Public filing date
Aug 3, 2026
Filing lag
Filed same day
ALKS daily price context
Close on/before transaction
$49.53
Aug 3, 2026
First close after public filing
$49.67
Aug 4, 2026
30-day return after filing
-3.93%
Through Sep 2, 2026
Source details
- Reported owner
- Not disclosed
- Source asset code
- Security
- Security
- Ordinary Shares
- Quantity / price
- 9,000 shares @ $48.58
- SEC ownership
- Direct
- Transaction code
- S
- Form
- 4
- Filing identifier
- 0001520262-26-000110
Filing cohort
Transactions in this filing
Showing 5 of 5
Trades
5
Issuers
1
Estimated value
$559.62K
Buys / sales
0 / 1
| Issuer | Transaction | Traded | Value |
|---|---|---|---|
| Alkermes Plc. ALKS | Exercise | Aug 3, 2026 | $120.39K |
| Alkermes Plc. ALKS | Exercise | Aug 3, 2026 | $0 |
| Alkermes Plc. ALKS Current | Sale | Aug 3, 2026 | $437.22K |
| Alkermes Plc. ALKS | Exercise | Aug 3, 2026 | $2.01K |
| Alkermes Plc. ALKS | Exercise | Aug 3, 2026 | $0 |